EADV:2014慢性荨麻疹管理指南

2016-07-18 欧洲皮肤病与性病学会

EADV:2014慢性荨麻疹管理指南 

中文标题:

EADV:2014慢性荨麻疹管理指南

英文标题:

Management and treatment of chronic urticaria (CU)

发布日期:

2016-07-18

简要介绍:

EADV:2014慢性荨麻疹管理指南 

相关资料下载:
[AttachmentFileName(sort=100, fileName=EADV:2014慢性荨麻疹管理指南)] GetToolGuiderByIdResponse(projectId=1, id=6db821c00123e7be, title=EADV:2014慢性荨麻疹管理指南, enTitle=Management and treatment of chronic urticaria (CU), guiderFrom=, authorId=null, author=, summary=EADV:2014慢性荨麻疹管理指南 , cover=, journalId=null, articlesId=null, associationId=1016, associationName=欧洲皮肤病与性病学会, associationIntro=EADV is a non-profit association, founded in 1987, whose mission is to advance excellence in clinical care, research, education and training in the field of dermatology and Venereology and to act as the advocate and educator of patients particularly those with cutaneous or venereal diseases., copyright=0, guiderPublishedTime=Mon Jul 18 11:47:36 CST 2016, originalUrl=, linkOutUrl=, content=EADV:2014慢性荨麻疹管理指南 , tagList=[TagDto(tagId=100842, tagName=慢性荨麻疹)], categoryList=[CategoryDto(categoryId=39, categoryName=皮肤性, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=null, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3125, appHits=504, showAppHits=0, pcHits=1875, showPcHits=1038, likes=157, shares=22, comments=2, approvalStatus=1, publishedTime=Mon Jul 18 11:47:36 CST 2016, publishedTimeString=2016-07-18, pcVisible=1, appVisible=1, editorId=5295946, editor=kelly, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=kelly, createdTime=Mon Jul 18 11:47:36 CST 2016, updatedBy=null, updatedName=null, updatedTime=Thu Jan 04 18:54:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=EADV:2014慢性荨麻疹管理指南)])
EADV:2014慢性荨麻疹管理指南
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1067416, encodeId=4425106e41668, content=指南不错,很有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab95197944, createdName=1472e9b1m78暂无昵称, createdTime=Fri Nov 05 22:37:24 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807360, encodeId=833780e36013, content=慢性荨麻疹治疗目标是缓解症状。主要用药是抗组胺药。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=168f5395359, createdName=ms5000000322775946, createdTime=Mon Aug 10 22:28:01 CST 2020, time=2020-08-10, status=1, ipAttribution=)]
    2021-11-05 1472e9b1m78暂无昵称

    指南不错,很有价值

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1067416, encodeId=4425106e41668, content=指南不错,很有价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4ab95197944, createdName=1472e9b1m78暂无昵称, createdTime=Fri Nov 05 22:37:24 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807360, encodeId=833780e36013, content=慢性荨麻疹治疗目标是缓解症状。主要用药是抗组胺药。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=168f5395359, createdName=ms5000000322775946, createdTime=Mon Aug 10 22:28:01 CST 2020, time=2020-08-10, status=1, ipAttribution=)]
    2020-08-10 ms5000000322775946

    慢性荨麻疹治疗目标是缓解症状。主要用药是抗组胺药。

    0